GlobeNewswire Inc.··DelveinsightIgA Nephropathy Market Set to Nearly Quadruple by 2036 Amid Novel Therapy Wave
IgA Nephropathy market projects 18.6% CAGR through 2036 from $1.5B base, driven by novel immunotherapies and recent FDA approvals reshaping kidney disease treatment.
NVSVRTXRHHBYAZNTAK+4clinical trialsgene therapy